AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+1.29%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$8.89B
AUM Growth
-$1.49B
(-14%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-17.93%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124
Top Buys
| 1 |
Energy Transfer Partners
ET
|
+$33.8M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$30.5M |
| 3 |
Newmont
NEM
|
+$30M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
| 5 |
Conagra Brands
CAG
|
+$24.9M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$430M |
| 2 |
JPMorgan Chase
JPM
|
+$162M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$132M |
| 4 |
Pfizer
PFE
|
+$111M |
| 5 |
Yum! Brands
YUM
|
+$105M |
Sector Composition
| 1 | Energy | 59.33% |
| 2 | Technology | 6.01% |
| 3 | Healthcare | 4.63% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Financials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Humana
HUM
$36.8B
| $1.36M | 0.02% |
2,941
-288
| -9% | -$134K |
|
327
LXP Industrial Trust
LXP
$2.68B
| $1.33M | 0.02% |
85,091
-9,792
| -10% | -$153K |
|
328
Catalyst Pharmaceutical
CPRX
$2.48B
| $1.32M | 0.01% |
194,494
-5,906
| -3% | -$40K |
|
329
Syndax Pharmaceuticals
SNDX
$1.37B
| $1.27M | 0.01% |
58,179
-1,414
| -2% | -$31K |
|
330
MannKind Corp
MNKD
$1.72B
| $1.27M | 0.01% |
+290,784
| New | +$1.27M |
|
331
RAPT Therapeutics
RAPT
$225M
| $1.26M | 0.01% |
4,274
-243
| -5% | -$71.4K |
|
332
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$15.7B
| $1.22M | 0.01% |
23,822
-75
| -0.3% | -$3.85K |
|
|
EFC
333
Ellington Financial
EFC
$1.37B
| $1.22M | 0.01% |
+71,495
| New | +$1.22M |
|
334
National Health Investors
NHI
$3.72B
| $1.22M | 0.01% |
21,252
-75
| -0.4% | -$4.31K |
|
|
RC
335
Ready Capital
RC
$731M
| $1.21M | 0.01% |
+77,450
| New | +$1.21M |
|
336
Day One Biopharmaceuticals
DAWN
$754M
| $1.21M | 0.01% |
+71,668
| New | +$1.21M |
|
337
Arcutis Biotherapeutics
ARQT
$2.11B
| $1.21M | 0.01% |
58,203
-3,375
| -5% | -$70K |
|
338
Omega Healthcare
OHI
$12.7B
| $1.2M | 0.01% |
40,531
+23,850
| +143% | +$706K |
|
339
Sabra Healthcare REIT
SBRA
$4.58B
| $1.18M | 0.01% |
87,243
+6,972
| +9% | +$94.4K |
|
340
Artisan Partners
APAM
$3.29B
| $1.17M | 0.01% |
24,552
-239
| -1% | -$11.4K |
|
|
PMT
341
PennyMac Mortgage Investment
PMT
$1.09B
| $1.16M | 0.01% |
+67,057
| New | +$1.16M |
|
342
Annaly Capital Management
NLY
$14.3B
| $1.16M | 0.01% |
+36,932
| New | +$1.16M |
|
343
SiriusXM
SIRI
$8.13B
| $1.15M | 0.01% |
18,149
-2,058
| -10% | -$131K |
|
344
MacroGenics
MGNX
$108M
| $1.14M | 0.01% |
70,889
-4,008
| -5% | -$64.3K |
|
345
Immunovant
IMVT
$2.86B
| $1.13M | 0.01% |
133,092
-7,860
| -6% | -$67K |
|
346
Arcturus Therapeutics
ARCT
$478M
| $1.13M | 0.01% |
30,505
-1,754
| -5% | -$64.9K |
|
347
Estee Lauder
EL
$32B
| $1.12M | 0.01% |
3,012
-192
| -6% | -$71.1K |
|
348
uniQure
QURE
$954M
| $1.11M | 0.01% |
+53,470
| New | +$1.11M |
|
349
AnaptysBio
ANAB
$618M
| $1.11M | 0.01% |
31,831
-1,792
| -5% | -$62.3K |
|
|
CMPS
350
Compass Pathways
CMPS
$492M
| $1.07M | 0.01% |
+48,290
| New | +$1.07M |
|